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Abstract
Impaired cardiorespiratory fitness is associated with inferior survival in patients preparing to 
undergo hematopoietic cell transplantation (HCT). Exercise training based on short, higher-
intensity intervals has the potential to efficiently improve cardiorespiratory fitness. We studied 
home-based interval exercise training (IET) in 40 patients prior to autologous (N=20) or allogeneic 
(N=20) HCT. Each session consisted of 5, three-minute intervals of walking, jogging, or cycling at 
65-95% maximal heart rate (MHR) with 3 minutes of low intensity exercise (<65% MHR) 
between intervals. Participants were asked to perform sessions at least 3 times weekly. The 
duration of the intervention was at least 6 weeks, depending on each patient’s scheduled 
transplantation date. Cardiorespiratory fitness was assessed from a peak oxygen consumption test 
(VO2peak) and a 6 minute walk (6MWD) before and after the intervention period. For the 
autologous HCT cohort, improvements in VO2peak (p=0.12) and 6MWD (p=0.19) were not 
statistically significant. For the allogeneic cohort, the median VO2peak improvement was 3.7ml/
kg*min (p=0.005) and the median 6MWD improvement was 34 meters (p=0.006). Home-based, 
interval exercise training can be performed prior to HCT and has the potential to improve 
cardiorespiratory fitness.
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 Introduction
There is mounting evidence that cardiorespiratory fitness is strongly associated with survival 
in cancer and non-cancer populations 1-4. Impaired cardiorespiratory fitness may also be 
associated with the development of malignancy 5-7. Within the field of exercise physiology, 
cardiopulmonary exercise testing performed using indirect calorimetry is considered the 
gold standard for the assessment of maximal oxygen uptake, and may predict who is more 
likely to survive hematopoietic cell transplantation (HCT) 8-10. Due to the association of 
cardiorespiratory fitness with mortality, several investigators have developed exercise 
programs for cancer patients, with results suggesting a net positive impact of exercise upon 
health-related quality of life, treatment toxicity, relapse incidence, and overall mortality in 
several cancer settings 11-15.
Currently, most exercise recommendations for cancer patients are directed toward survivors, 
and statements about intensity are general in nature 16. Many of the exercise studies in 
cancer have been performed in patients with breast cancer, and transplant exercise studies 
have usually been performed in the post-transplant setting 17. However, peri-transplant 
exercise interventions have potential to mitigate post-transplant toxicity. Wiskemann et al. 18 
demonstrated significant improvements in post-transplant fatigue and physical fitness/
functioning as a result of moderate peri-transplant exercise, and also showed that exercise 
after allogeneic transplant may improve mortality.19 Though a large, recently conducted 
study of peri-transplant exercise training did not demonstrate an improvement in post-
transplant health-related quality of life, this study had a very different design than the above 
studies and was an intervention of significantly lower intensity. 20
Recent evidence supports the use of higher intensity exercise as an approach for inducing 
rapid improvements in cardiorespiratory fitness 21, 22. As a result of the intense treatment 
utilized in HCT, and the accompanying effects of HCT treatment upon cardiorespiratory 
fitness, pulmonary function, and skeletal muscle capacity, exercise intensity may be an 
important factor in this population to mitigate transplant toxicity 23, 24. Higher intensity 
exercise approaches have begun to be explored in cancer patients 25-27. Home-based training 
utilizing higher-intensity intervals of exercise may offer several advantages, including 
modifiability to fit the needs of patients, adaptability to the home setting, and requirement of 
less overall time than traditional approaches to improve fitness 28-30.
The purpose of this study was to evaluate the feasibility and physiological effects of a home-
based interval exercise training (IET) intervention for cancer patients in the pre-
hematopoietic stem cell transplant period. We sought to address a key limitation in the field 
of exercise oncology research, namely that home-based exercise prescriptions are 
insufficiently personalized and/or lacking the appropriate adaptability and intensity 
necessary to achieve improvements in fitness and long-term cancer outcomes. We also 
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wished to evaluate the physiological effects from a tailored program that patients could 
realistically complete in the pre-transplant period. We drew upon data from supervised high-
intensity interval training in other populations suggesting that interval-based exercise 
efficiently improves cardiorespiratory fitness within a period of weeks 30, 31. We 
hypothesized that a home-based, interval training intervention, personalized by targeting 
participant heart rate percentages derived from individual maximal heart rates during 
exercise testing, could be feasibly performed by cancer patients in the weeks leading up to 
HCT. This hypothesis was tested in separate cohorts of autologous and allogeneic pre-
transplant patients.
 Materials and Methods
 Participants
Participants between the ages of 18-75 years were recruited from among patients preparing 
to undergo autologous or allogeneic HCT at the University of North Carolina from 07/2013 
through 10/2014 (Table 1). In order to participate, patients had an upcoming planned 
autologous or allogeneic transplant with enough time to accommodate a six week exercise 
intervention. Participants could not have received erythropoiesis-stimulating agents (ESAs) 
within four weeks prior to enrollment, nor could they have a comorbid illness that would 
preclude participation in maximal effort exercise testing or regular exercise, as determined 
by the treating physicians. Of the 98 patients approached for enrollment and meeting 
eligibility criteria, 49 agreed to participate, signing an approved consent form (Figure 1). Of 
the 49 that consented, 9 withdrew from the study as a result of a change in treatment plan, 
disease progression, or lack of interest. The final cohort analyzed was a total of 40 patients 
(20 autologous and 20 allogeneic transplant recipients). This protocol was approved by the 
Biomedical Institutional Review Board at the University of North Carolina and all 
procedures are in accordance with the Helsinki Declaration of 1975. All participants 
provided written informed consent prior to participation in any study-related activities
 Physiological Testing
Physiological testing occurred before and after the 6-week home-based IET program. All 
participants underwent baseline maximal cardiopulmonary exercise testing (CPET) with 
cycle ergometry (VO2peak) as previously described 9. Briefly, this graded exercise test was 
completed on an electronically braked cycle ergometer (Corival 400, Lode, Gronigen, The 
Netherlands). Participants were fitted with a facemask (NRB1, Hans Rudolph Inc., Kansas 
City, MO) in order to ensure a secure seal around the nose and mouth. Participants 
completed a 2 minute warm-up with no resistance, maintaining pedal cadence between 
50-70 rpm. The initial stage was set to 25 watts (W) for all participants. Subsequent stages 
were increased based on the subject’s fitness level and leg strength (10-25W), as determined 
by an exercise physiologist. Workloads were kept consistent for pre- and post-testing. 
Respiratory gases were monitored continuously and analyzed with open-circuit spirometry 
using a calibrated metabolic cart (True One 2400, Parvomedics, Provo, UT). Data was 
averaged over 15-seconds, with the three highest 15-second oxygen consumption values 
from the final minute identified as VO2peak. Heart rate was monitored continuously 
throughout the duration of the protocol using a polar heart rate strap (Model FT1, Polar, Inc., 
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Lake Success, NY). The VO2peak test was conducted to determine cardiorespiratory fitness 
and to establish participant-specific maximal heart rates (MHR). A 6-minute walk distance 
(6MWD) was also obtained at baseline using a standardized protocol. Patients walked a 15 
meter flat corridor unaccompanied, turning 180° every 15 m in the allotted 6 minute time 
frame. Patients were allowed to rest if needed, and time remaining was called every 2 
minutes. After the 6 minutes, total distance travelled was calculated, and was reported as the 
6MWD.
 Interval Exercise Training
Following baseline exercise testing, participants were educated about how to participate in 
IET at home using target heart rates established from the VO2peak test. An exercise 
physiologist discussed which mode might be most advantageous for that patient to achieve 
target heart rates. Modes performed by the participants included variations in walking, 
running, and/or cycling; participants were encouraged to maintain the same mode 
throughout the duration of the study. All participants were provided with heart rate monitors 
(FTI, Polar Inc.) to facilitate training. Monitors were set according to calculated training 
zones, providing a beep when a patient achieved the HR zone. For weeks one and two of the 
6-week home-based intervention, participants were asked to perform three, 30 minute 
walking sessions with one, 3-minute higher intensity interval (60-70% MHR) per session. 
For the subsequent 4 weeks, participants were asked to perform a greater volume and 
intensity of IET training consisting of five, 3-minute higher intensity intervals (65-95% 
MHR) during each 30 minute session, 3 times per week. Participants were instructed to 
reduce intensity or rest between intervals (Figure 2). Because participants were allowed to 
train at an MHR as low as 65%, this was not strictly a high intensity training program by 
American College of Sports Medicine (ACSM) standards,32 though most participants did 
achieve a high percentage of MHR (see results). All training sessions were recorded on a 
paper log, including maximum heart rate achieved per session and date of completion. 
Additionally, all participants were provided with accelerometers (FitBit Flex, Fitbit, Inc., 
San Francisco, CA) and were instructed to wear these throughout the duration of the home-
based exercise intervention, through hospitalization for transplant, and for four weeks post 
discharge. Participants were also instructed to record completion of each session and 
maximum heart rate achieved per session on an interval training log. Weekly calls were 
provided by the study team in order to provide motivation, answer questions, and to address 
potential issues such as a declining health status, equipment dysfunction, or intervention 
related adverse events. Participants were also encouraged to contact the study team at any 
time to discuss any issues encountered during the IET program. After the completion of the 
IET program and prior to transplantation, participants underwent the same fitness 
assessments performed at baseline which included a maximal cardiopulmonary exercise test 
(VO2peak) and 6MWD.
 Statistical Analysis
Descriptive statistics (including medians, interquartile ranges (IQR), and percentages) were 
calculated for both cohorts separately. Feasibility of the program was evaluated by 
adherence data, including number of weeks completed and number of IET sessions initiated 
and completed, respectively. Physiological effects (e.g. VO2peak, 6MWD) were evaluated 
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on the change scores from pre to post-training using Wilcoxon Signed Rank tests, with a p-
value of less 0.05 considered significant. Sample size for this study was based on previous 
data from the authors 30, anticipating a 2 ml/kg*min change in VO2peak with a standard 
deviation of 2.5 ml/kg*min. A total of 20 patients, in this single arm, non-randomized 
intervention, were needed to achieve 92% power. Due to the novelty of the intervention and 
the ability to evaluate autologous and allogeneic groups separately, 20 patients per group 
were recruited. Analyses were conducted using SAS Statistical Software (version 9.3, Cary, 
NC).
 Results
Of the 40 total patients enrolled, disease classification consisted of acute myeloid leukemia 
(n=6 allo); acute lymphoblastic leukemia (n=2 allo); multiple myeloma (n=13 auto; n=1 
allo), chronic myeloid leukemia (n=1 auto; n=2 allo); myelodysplastic syndrome (n=4 allo); 
non hodgkin lymphoma (n=3 auto; n=1 allo); myelofibrosis (n=1 allo); aplastic anemia (n=1 
allo) and other (n=3 auto; n=1 allo).
 Adherence and Efficacy
 Autologous Transplant Cohort—Among pre- autologous transplant recipients, most 
patients (n=16) had at least 6 weeks before their transplant, with the remaining having 3-5 
weeks available prior to transplant. For the 20 patients in this group, 6 (30%) participated in 
more than 75% of the training sessions. The entire group completed a median of 39% of the 
IET sessions. Among all autologous recipients, initiation of a median of 7 total IET sessions 
(IQR 3-15) were recorded during the intervention period. The median duration of each IET 
session was 30 minutes. The highest recorded maximal heart rate percentage (MHR, from 
the Karvonen Prediction Equation) achieved at any time during IET sessions was a median 
of 94.6% MHR. Recorded daily activity of participants using accelerometry was a median of 
5546 steps per week (IQR 3929-7469) throughout the intervention period.
Evaluation of the physiological change from pre- to post-intervention for VO2peak 
demonstrated a median increase of 1.1 ml/kg*min (p=0.121), and a median increase of 
30.1m for the 6MWD (p=0.19) (Table 2 and Figure 3).
 Allogeneic Transplant Cohort—Among pre-allogeneic transplant recipients, all 
patients had 6 weeks available prior to transplant. Of the 18 total sessions available, 7 (35%) 
completed more than 75% of the IET sessions; the entire group completed a median of 47% 
of the IET sessions. Allogeneic recipients recorded initiation of a median of 11 total IET 
sessions (IQR 5-16). The median duration of each IET session was 30 minutes. The highest 
recorded maximal heart rate (MHR) percentage achieved at any time during IET sessions 
was a median of 91.3% MHR for the allogeneic cohort. Allogeneic recipients walked a 
median of 5178 steps per week (IQR 4186-6554) throughout the intervention period.
Analysis of VO2peak from pre- to post-intervention demonstrated a significant median 
improvement of 3.7 ml/kg*min (p=0.005) and a significant median improvement in 6MWD 
of 34m (p=0.006) in this cohort.
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 Safety and Adverse Events
There were no study-related adverse events identified in either the autologous or allogeneic 
cohort that were directly related to the exercise testing or exercise intervention. Adverse 
events could be reported by the study team, nursing staff, treating clinicians, or the patients 
themselves.
 Discussion
This is one of the first reports of a home-based, personalized, interval exercise training 
program in cancer patients preparing to undergo hematopoietic cell transplantation. Our data 
show that the personalized IET program, based on maximal heart rate, could be performed at 
home and appeared to be safe. The IET intervention also resulted in improvements in 
cardiorespiratory fitness in patients, most notably in the pre-allogeneic transplant group. 
These findings are of clinical relevance, as pre-transplant cardiorespiratory fitness has been 
demonstrated to predict post-transplant survival 9.
Interestingly, the present results demonstrate that VO2peak values significantly improved 
after the exercise intervention in the pre-allogeneic transplant population, but 
cardiorespiratory fitness changes were not significant in the pre-autologous transplant 
population. Rates of adherence, and achievement of target heart rates, did not appear to 
differ significantly between these two cohorts, and despite the non-significance, the pre-
autologous group did demonstrate a small median improvement in VO2peak. However, the 
differences between groups may be partially explained by a number of the autologous 
transplant patients undergoing stem cell mobilization and collection during or overlapping 
with the IET program. This observation is important for a few reasons. First, our data show 
that IET appears to be feasible and safe around the time of mobilization and collection. 
Second, it is possible that stem cell mobilization has a detrimental impact upon 
cardiorespiratory fitness as measured by CPET. On the other hand, the autologous transplant 
cohort appeared to experience rapid collection and robust stem cell yields. In this cohort, 
100% underwent successful stem cell mobilization on the first attempt, using either 
etoposide chemo-mobilization or G-CSF mobilization per institutional protocol. 74% of 
patients collected adequate cells within 1 day of collection, with all other patients, except for 
1 collecting within 2 days (the exception was a patient with a higher collection target to 
support 3 auto transplants for germ cell tumor, who required a third day). The median total 
stem cell dose collected for the autologous cohort was 6.2 × 106/kg CD34+ cells, with 5 
patients collecting more than 10 × 106/kg and 1 patient collecting 32.4 × 10 6/kg CD34+ 
cells. Pre-clinical and clinical data suggests that exercise may enhance progenitor cell 
mobilization, lending some biological plausibility to these findings and suggesting further 
study in this area 33-35.
In contrast to the autologous cohort, the pre-allogeneic transplant cohort experienced a 
significant improvement in VO2peak measurements. The median improvement of 3.7 ml/
kg*min represents a significant benefit in cardiorespiratory fitness for a short term 
intervention. It is possible that the interval-based nature of the intervention might help to 
explain this observation, as supervised interval training programs have been associated with 
efficient improvements in cardiorespiratory fitness in short periods of time in other, non-
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cancer populations 30, 36, 37. A randomized study would be required to demonstrate that the 
IET protocol was ultimately responsible for the fitness improvements that were seen in our 
pre-allogeneic transplant population, and to determine whether cardiorespiratory fitness 
improvements translate into improved post-transplant outcomes. Of note, it was apparent 
that responses and non-responses in the allogeneic transplant cohort could not be attributed 
solely to the degree of participation in the interval exercise training sessions. It is possible 
that factors related to underlying individual physiology or disease- or treatment-related 
effects may have contributed to differential responses among participants with similar levels 
of participation (or non-participation) in the intervention. Larger studies will be needed to 
adequately account for other potential predictors of response to this exercise intervention.
We acknowledge several limitations to this pilot study, and opportunities for improvement in 
follow-up work that will test the hypothesis that pre-transplant interval exercise training 
improves pre-transplant fitness and potentially post-transplant outcomes and survival. First, 
this was a non-randomized study with a relatively small sample, with findings that need 
validation in larger, randomized cohorts. Second, though we allowed a relatively wide range 
of targeted % MHR for the interval training, supported by the observation that exercise 
intensity ranges may be defined differently in cancer patients undergoing transplant than in 
healthy individuals 38. Third, the recruitment rate of eligible patients was not as high as 
observed in previous pre-transplant exercise studies. It is possible that the intensity of our 
intervention may have dissuaded potential participants, though other reversible workflow 
limitations in our clinical environment may have also influenced recruitment, which we plan 
to address in future studies. For example, improving the logistics of testing sessions around 
convenient times for patients, many of whom were traveling significant distances to our 
cancer center, would have facilitated better recruitment and will be addressed in subsequent 
work. Fourth, while feasible and safe, participation in the weekly interval sessions was lower 
than desired. However, participants reported maximal heart rates during their interval 
training that that were within the prescribed intensity range for the intervention. 
Additionally, because of the frequency and complexity of the home-based intervention, 
adherence rates may have been underestimated, as it was challenging for participants to 
remember to reliably record each completed session using paper diaries. Regardless, the 
observed improvements in cardiorespiratory fitness in the allogeneic cohort suggest that a 
low “dose” of interval training may be sufficient to achieve improvement in VO2peak. 
Further improvements to the study procedures to increase and reliably ascertain adherence to 
the home-based intervention may provide more confidence around the dose effect estimates 
of the intervention, and may potentially lead to even greater improvements in 
cardiorespiratory fitness.
Several strategies are available to improve motivation and adherence to this intervention in 
future work. For example, the rapid development and improvement of wearable technology 
offers the opportunity to further facilitate the uptake of home-based, personalized exercise 
prescriptions in transplant and non-transplant populations 39. Several commercially-available 
wearable devices now provide continuous heart rate tracking capabilities without the need 
for additional equipment, as was required in our protocol, and enable users to customize 
exercise bouts and heart rate targets. Importantly, the data tracking capabilities of these 
devices have significant potential to improve estimates of adherence, and potentially to 
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eliminate the need for participants to manually log each completed IET session in a separate 
exercise diary. We anticipate that these capabilities may facilitate better intervention 
adherence in future personalized, home-based exercise prescription protocols.
Home-based, personalized intensive exercise programs have the potential to improve 
cardiorespiratory fitness in patients preparing to undergo hematopoietic cell transplantation. 
These programs may be applicable in many settings in which rapid improvement in 
physiological reserve is a key goal, including the pre-transplant and pre-surgical settings, but 
also among cancer survivors in general and potentially in the setting of certain types of 
chemotherapy. Just as there is a national movement towards the application of precision 
medicine within cancer treatment, the time is also right for the personalized application of 
exercise programming to improve long-term cancer outcomes.
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Figure 1. 
Flow diagram.
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Figure 2. 
Overview of Exercise Intervention
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Figure 3. 
VO2peak (a) and 6MWD (b) changes on an individual participant basis. Red vertical lines 
represent participants from the autologous transplant cohort, and black vertical lines 
represent participants from the allogeneic transplant cohort.
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Table 1
Patient characteristics at baseline testing. Values are presented as median [IQR].
Gender Age (yrs) Height (cm) Weight (kg)
Body Mass
Index (kg/m2)
Autologous (n=20)
14 Male
6 Female
60.5
[54.5 - 68.0]
172.8
[165.5 - 177.25]
85.0
[73.4 - 97.8]
28.6
[26.5 - 31.0]
Allogeneic (n=20)
12 Male
8 Female
52.5
[45.0 - 63.0]
171.6
[162.6 - 180.0]
75.4
[68.7 - 97.9]
27.0
[23.6 - 31.2]
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